Femasys Inc. vs NeuroPace
Femasys Inc. vs NeuroPace, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Femasys Inc. is on 44/100 and NeuroPace on 67/100.
Where each one leads
Femasys Inc.
Leads on none of the measures we hold for both companies.
NeuroPace
- our overall score: 67/100 against 44/100
- agent readiness: 47/100 against 36/100
- domain rating: 53/100 against 39/100
- funding raised: $475M against $34.0M
At a glance
| Measure | Femasys Inc. | NeuroPace |
|---|---|---|
| What it is | Femasys is a biomedical company developing minimally invasive, in-office technologies for women's reproductive health, including fertility and permanent birth control solutions. | Develops a brain-computer interface for treating epilepsy. |
| Category | MedTech, Biotech, Women's Health, Reproductive Health | MedTech, HealthTech, Brain-Computer Interface, Non-Invasive BCI |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Hardware |
| Founded | 2004 | 1997 |
| Headquarters | Suwanee, United States | Mountain View, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Femasys Inc. | NeuroPace |
|---|---|---|
| Employees | Not published | 248 |
| Total funding | $34.0M | $475M |
| Latest round | IPO | IPO |
| Valuation | Not published | $375M |
| LinkedIn followers | Not published | 32,261 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Femasys Inc. | NeuroPace |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 67/100 |
| Traction | 38/100 | 60/100 |
| Team | Not published | 70/100 |
| Search visibility | Not published | 35/100 |
| Quality | 62/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (36/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 39/100 | 53/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Femasys Inc. | NeuroPace |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Tailwind CSS, Bootstrap | Jquery |
| Analytics | Not detected | Google Tag Manager, Hotjar |
Femasys Inc. vs NeuroPace: common questions
Which is better, Femasys Inc. or NeuroPace?
On our 0-100 score NeuroPace rates higher (67/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Femasys Inc. and NeuroPace compare on the numbers?
NeuroPace leads on our overall score (67/100 against 44/100), agent readiness (47/100 against 36/100), domain rating (53/100 against 39/100), funding raised ($475M against $34.0M).
Read the full Femasys Inc. review and pricing or the NeuroPace review and pricing. You can also browse other Femasys Inc. alternatives we track.